No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Monday, October 6, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

Pfizer battles another Paxlovid lawsuit from Enanta

by TheAdviserMagazine
2 months ago
in Business
Reading Time: 2 mins read
A A
Pfizer battles another Paxlovid lawsuit from Enanta
Share on FacebookShare on TwitterShare on LInkedIn


If you don’t succeed at first, try again – in separate regions. That’s the motto Enanta Pharmaceuticals is following, at least, after disclosing it has sued Pfizer in Europe over a patent infringement relating to Covid-19 treatment pill Paxlovid (nirmatrelvir/ritonavir).

In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma company infringed on a patent describing protease inhibitors invented by its scientists. Enanta has now followed that up with another filing in Europe, making the same accusation.

Since being emergency authorised in 2021, anti-viral Paxlovid has generated Pfizer more than $26bn in global revenue. This includes a staggering $18.9bn in 2022 when Covid-19 cases were still prevalent. Despite waning demand for Covid-19 treatments, the pill still brought in $1.2bn in 2024, buoyed by government orders.

However, Enanta – known for co-developing hepatitis C virus treatment glecaprevir/pibrentasvir with AbbVie – believes Pfizer designed Paxlovid via unlawful means.

The US biotech stated it is “seeking a determination of liability for use and infringement of European Patent No. EP 4 051 265 (the ’265 Patent) in the manufacture, use and sale of Pfizer’s Covid-19 antiviral, Paxlovid”.

In an emailed statement to Pharmaceutical Technology, a Pfizer spokesperson said: “We are confident in our intellectual property (IP) surrounding Paxlovid and will respond in due course in court.”

The lawsuit, filed in the European Union’s (EU) Unified Patent Court (UPC), targets Pfizer’s commercial activity in the 18 countries of the EU. The company confirmed the ’265 patent in question is the European counterpart of US patent number 11,358,953 (the ’953 Patent) that is the centre of the US lawsuit.

Although it is technically ongoing, Enanta’s US lawsuit hit a major roadblock. In December 2024, a federal judge in Massachusetts sided with Pfizer, granting that the ‘953 patent is invalid. Enanta confirmed at the time it would appeal the decision, adding it “believes strongly in the merits of our case”.

Pfizer reported strong Q2 2025 results this month, bucking a tepid earnings window that gripped the wider pharma industry. Sales for the Paxlovid grew 71% while the Covid-19 vaccine Comirnaty revenue surged 95%.

However, the legal challenge posed by Enanta marks the second issue Pfizer has had to firefight this week. The big pharma company reported a Phase III trial failure for a sickle cell disease candidate purchased as part of a $5.4bn takeover of Global Blood Therapeutics in 2022.

“Pfizer battles another Paxlovid lawsuit from Enanta” was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

 

The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.



Source link

Tags: battlesEnantaLawsuitPaxlovidPfizer
ShareTweetShare
Previous Post

Payment Delays Hit 40% of UK Crypto Investors, Banks Point to Fraud

Next Post

Navigate With Confidence The Migration Options For SAP ECC Customers

Related Posts

edit post
David Ellison says he’s confident Bari Weiss ‘will invigorate CBS News’ as new editor-in-chief

David Ellison says he’s confident Bari Weiss ‘will invigorate CBS News’ as new editor-in-chief

by TheAdviserMagazine
October 6, 2025
0

Paramount said Monday that it has bought the news and commentary website The Free Press and installed its founder, Bari...

edit post
Dow falls, S&P 500 and Nasdaq rise as AMD surges on OpenAI deal, shutdown drags on

Dow falls, S&P 500 and Nasdaq rise as AMD surges on OpenAI deal, shutdown drags on

by TheAdviserMagazine
October 6, 2025
0

US stocks were mixed on Monday as the federal government shutdown entered another week, while a megadeal between AMD (AMD)...

edit post
AMD signs AI chip-supply deal with OpenAI, shares surge 38%

AMD signs AI chip-supply deal with OpenAI, shares surge 38%

by TheAdviserMagazine
October 6, 2025
0

Shares of Advanced Micro Devices (AMD) surged 38% to hit a high of $226.70 on Nasdaq after the company announced...

edit post
Gen Z has a different attitude about dining from baby boomers and millennials—and it shows in smaller tickets at chain restaurants

Gen Z has a different attitude about dining from baby boomers and millennials—and it shows in smaller tickets at chain restaurants

by TheAdviserMagazine
October 6, 2025
0

When Mia Jones goes out to eat with her friends, she wants something that’s just right: not overly popular, but...

edit post
Should You Consider Adding Chipotle Mexican Grill (CMG) to Your Portfolio?

Should You Consider Adding Chipotle Mexican Grill (CMG) to Your Portfolio?

by TheAdviserMagazine
October 6, 2025
0

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” third-quarter 2025 investor letter. A copy of...

edit post
Inside the ultra-private one-room hotels redefining luxury travel

Inside the ultra-private one-room hotels redefining luxury travel

by TheAdviserMagazine
October 6, 2025
0

After the mangosteen daiquiri misted tableside with lime oil, the cheesy garlic naan, the broccoli salad with pistachios and mint,...

Next Post
edit post
Navigate With Confidence The Migration Options For SAP ECC Customers

Navigate With Confidence The Migration Options For SAP ECC Customers

edit post
Jackson Hole Preview: All Eyes on Powell as Fed Navigates Policy Tightrope

Jackson Hole Preview: All Eyes on Powell as Fed Navigates Policy Tightrope

  • Trending
  • Comments
  • Latest
edit post
What Happens If a Spouse Dies Without a Will in North Carolina?

What Happens If a Spouse Dies Without a Will in North Carolina?

September 14, 2025
edit post
California May Reimplement Mask Mandates

California May Reimplement Mask Mandates

September 5, 2025
edit post
Does a Will Need to Be Notarized in North Carolina?

Does a Will Need to Be Notarized in North Carolina?

September 8, 2025
edit post
DACA recipients no longer eligible for Marketplace health insurance and subsidies

DACA recipients no longer eligible for Marketplace health insurance and subsidies

September 11, 2025
edit post
‘Quiet luxury’ is coming for the housing market, The Corcoran Group CEO says. It’s not just the Hamptons, Aspen, and Miami anymore

‘Quiet luxury’ is coming for the housing market, The Corcoran Group CEO says. It’s not just the Hamptons, Aspen, and Miami anymore

September 9, 2025
edit post
Tips to Apply for Mental Health SSDI Without Therapy

Tips to Apply for Mental Health SSDI Without Therapy

September 19, 2025
edit post
David Ellison says he’s confident Bari Weiss ‘will invigorate CBS News’ as new editor-in-chief

David Ellison says he’s confident Bari Weiss ‘will invigorate CBS News’ as new editor-in-chief

0
edit post
Catalonia’s Sugary Beverage Tax Hasn’t Improved Public Health

Catalonia’s Sugary Beverage Tax Hasn’t Improved Public Health

0
edit post
Turning a ,000 Rental Property into a ,000/Month Rental Portfolio

Turning a $25,000 Rental Property into a $5,000/Month Rental Portfolio

0
edit post
How to Hire Movers in Six Steps

How to Hire Movers in Six Steps

0
edit post
The Weekly Notable Startup Funding Report: 10/6/25 – AlleyWatch

The Weekly Notable Startup Funding Report: 10/6/25 – AlleyWatch

0
edit post
US Dollar: Hawkish Fed Clues Likely to Fuel Rally Amid Yen Weakness This Week

US Dollar: Hawkish Fed Clues Likely to Fuel Rally Amid Yen Weakness This Week

0
edit post
David Ellison says he’s confident Bari Weiss ‘will invigorate CBS News’ as new editor-in-chief

David Ellison says he’s confident Bari Weiss ‘will invigorate CBS News’ as new editor-in-chief

October 6, 2025
edit post
How to Hire Movers in Six Steps

How to Hire Movers in Six Steps

October 6, 2025
edit post
Dow falls, S&P 500 and Nasdaq rise as AMD surges on OpenAI deal, shutdown drags on

Dow falls, S&P 500 and Nasdaq rise as AMD surges on OpenAI deal, shutdown drags on

October 6, 2025
edit post
Catalonia’s Sugary Beverage Tax Hasn’t Improved Public Health

Catalonia’s Sugary Beverage Tax Hasn’t Improved Public Health

October 6, 2025
edit post
Ethereum’s Price as Grayscale Launches Staking ETPs – ,331?

Ethereum’s Price as Grayscale Launches Staking ETPs – $7,331?

October 6, 2025
edit post
Paul Tudor Jones says ingredients are in place for massive rally before a ‘blow off’ top to bull market

Paul Tudor Jones says ingredients are in place for massive rally before a ‘blow off’ top to bull market

October 6, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • David Ellison says he’s confident Bari Weiss ‘will invigorate CBS News’ as new editor-in-chief
  • How to Hire Movers in Six Steps
  • Dow falls, S&P 500 and Nasdaq rise as AMD surges on OpenAI deal, shutdown drags on
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.